Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chitra Hosing

Showing results (91-100 of 234) with videos related to

Pageof 24
Sort By:
Bone Marrow Transplantation|September 28, 2024
High activity of the new myeloablative regimen of gemcitabine/clofarabine/busulfan for allogeneic transplant for aggressive lymphomasJeremy Ramdial, Ruitao Lin, Peter F Thall, et al.
American Journal of Hematology|December 11, 2022
Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remissionOren Pasvolsky, Rima M Saliba, Celina Ledesma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2019
Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning RegimensHossein Maymani, Paul Lin, Rima M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fractionMuzaffar H Qazilbash, Ali Imran Amjad, Suhail Qureshi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation FailureUri Rozovski, Ohad Benjamini, Preetesh Jain, et al.
Bone Marrow Transplantation|August 26, 2024
Gastrointestinal involvement refines prognosis in minnesota standard risk acute graft-vs.-host diseaseCurtis M Marcoux, Amin M Alousi, Jin Im, et al.
European Journal of Haematology|January 17, 2016
Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvementTalha Badar, Amanda Megan Cornelison, Nina D Shah, et al.
British Journal of Haematology|March 8, 2016
Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantationRohtesh S Mehta, Rima M Saliba, Julianne Chen, et al.
Blood Neoplasia|January 15, 2026
Phase 1B pilot study of itacitinib with alemtuzumab in patients with T-cell prolymphocytic leukemiaTapan M Kadia, Akhil Jain, Caitlin R Rausch, et al.
Leukemia & Lymphoma|July 28, 2010
Hematopoietic progenitor cell collection in patients with chronic myelogenous leukemia in complete cytogenetic remission after imatinib mesylate therapyQaiser Bashir, Marcos J De Lima, John D McMannis, et al.
Pageof 24

Showing results (91-100 of 234) with videos related to

Sort By:
Pageof 24
Bone Marrow Transplantation|September 28, 2024
High activity of the new myeloablative regimen of gemcitabine/clofarabine/busulfan for allogeneic transplant for aggressive lymphomasJeremy Ramdial, Ruitao Lin, Peter F Thall, et al.
American Journal of Hematology|December 11, 2022
Prognostic significance of measurable residual disease in patients with acute lymphoblastic leukemia undergoing allogeneic hematopoietic stem cell transplantation in second or later complete remissionOren Pasvolsky, Rima M Saliba, Celina Ledesma, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|January 15, 2019
Comparison of Outcomes of Allogeneic Hematopoietic Cell Transplantation for Multiple Myeloma Using Three Different Conditioning RegimensHossein Maymani, Paul Lin, Rima M Saliba, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 15, 2009
Outcome of allogeneic hematopoietic stem cell transplantation in patients with low left ventricular ejection fractionMuzaffar H Qazilbash, Ali Imran Amjad, Suhail Qureshi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 8, 2015
Outcomes of Patients With Chronic Lymphocytic Leukemia and Richter's Transformation After Transplantation FailureUri Rozovski, Ohad Benjamini, Preetesh Jain, et al.
Bone Marrow Transplantation|August 26, 2024
Gastrointestinal involvement refines prognosis in minnesota standard risk acute graft-vs.-host diseaseCurtis M Marcoux, Amin M Alousi, Jin Im, et al.
European Journal of Haematology|January 17, 2016
Outcome of patients with systemic light chain amyloidosis with concurrent renal and cardiac involvementTalha Badar, Amanda Megan Cornelison, Nina D Shah, et al.
British Journal of Haematology|March 8, 2016
Post-transplantation cyclophosphamide versus conventional graft-versus-host disease prophylaxis in mismatched unrelated donor haematopoietic cell transplantationRohtesh S Mehta, Rima M Saliba, Julianne Chen, et al.
Blood Neoplasia|January 15, 2026
Phase 1B pilot study of itacitinib with alemtuzumab in patients with T-cell prolymphocytic leukemiaTapan M Kadia, Akhil Jain, Caitlin R Rausch, et al.
Leukemia & Lymphoma|July 28, 2010
Hematopoietic progenitor cell collection in patients with chronic myelogenous leukemia in complete cytogenetic remission after imatinib mesylate therapyQaiser Bashir, Marcos J De Lima, John D McMannis, et al.
Pageof 24